B. Coffin, Syndrome de l???intestin irritable : diagnostic chez l???adulte, Gastroent??rologie Clinique et Biologique, vol.33, pp.9-16, 2009.
DOI : 10.1016/S0399-8320(09)71520-9

S. J. Lewis and K. W. Heaton, Stool Form Scale as a Useful Guide to Intestinal Transit Time, Scandinavian Journal of Gastroenterology, vol.10, issue.9, pp.920-924, 1997.
DOI : 10.1046/j.1365-2036.1996.d01-506.x

H. Duboc, M. Dior, and B. Coffin, Le syndrome de l???intestin irritable??: nouvelles pistes physiopathologiques et cons??quences pratiques, La Revue de M??decine Interne, vol.37, issue.8, pp.536-543, 2016.
DOI : 10.1016/j.revmed.2015.12.030

M. Dapoigny, Syndrome de l???intestin irritable : ??pid??miologie/poids ??conomique, Gastroent??rologie Clinique et Biologique, vol.33
DOI : 10.1016/S0399-8320(09)71519-2

J. Sabaté and P. Jouet, Conseil de pratique : Prise en charge du Syndrome de l'Intestin Irritable (SII). 2013. Available at: http://www.snfge.org/download, p.287, 2016.

H. Autorité and D. Santé, Bon usage des technologies de santé : Quelles recherches d'anticorps prescrire dans la maladie coeliaque ? Available at: http://www.has.fr, 2008.

G. Bommelaer, T. Poynard, L. Pen, and C. , Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria, Gastroent??rologie Clinique et Biologique, vol.28, issue.6-7, pp.554-561, 2004.
DOI : 10.1016/S0399-8320(04)95011-7

S. Müller-lissner, S. Bollani, and R. Brummer, Epidemiological Aspects of Irritable Bowel Syndrome in Europe and North America, Digestion, vol.64, issue.3, pp.200-204, 2001.
DOI : 10.1159/000048862

P. Enck, Q. Aziz, and G. Barbara, Irritable bowel syndrome, Nature Reviews Disease Primers, vol.27, p.16014, 2016.
DOI : 10.1097/MEG.0000000000000428

S. Bruley-des-varannes, Syndrome de l???intestin irritable : aspects ??volutifs, Gastroent??rologie Clinique et Biologique, vol.33
DOI : 10.1016/S0399-8320(09)71529-5

M. Dapoigny, F. Dyard, and J. Grimaud, Troubles fonctionnels intestinaux et consommation de soins Available at: http://www.em-consulte, p.99442, 2008.

M. Amouretti, L. Pen, C. Gaudin, and A. , Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL), Gastroent??rologie Clinique et Biologique, vol.30, issue.2, pp.241-246, 2006.
DOI : 10.1016/S0399-8320(06)73160-8

P. Ducrotté, Physiopathologie et traitement des troubles fonctionnels intestinaux. EMC - Hépato-Gastroenterol, pp.400-412, 2005.

P. Ducrotté, Ballonnement abdominal : où en est-on ? Gastroentérologie Clin, Biol, vol.33, pp.94-100, 2009.

B. Coffin, M. Lémann, and R. Jian, Sensibilité viscérale digestive Available at: http://www.ipubli.inserm.fr/bitstream/handle, p.1, 1994.

A. Ropert and G. Bouguen, Troubles de la motricit?? intestinale et hypersensibilit?? visc??rale dans le syndrome de l???intestin irritable, Gastroent??rologie Clinique et Biologique, vol.33, pp.35-39, 2009.
DOI : 10.1016/S0399-8320(09)71523-4

B. Coffin, J. Sabaté, and D. Bouhassira, Douleurs et syndrome de l???intestin irritable, Gastroent??rologie Clinique et Biologique, vol.29, issue.8-9
DOI : 10.1016/S0399-8320(05)86345-6

R. Spiller and K. Garsed, Postinfectious Irritable Bowel Syndrome, Gastroenterology, vol.136, issue.6, pp.1979-1988, 2009.
DOI : 10.1053/j.gastro.2009.02.074

L. Bueno, M??canismes r??gulateurs de la perm??abilit?? des jonctions serr??es ??pith??liales du tube digestif, Cahiers de Nutrition et de Di??t??tique, vol.45, issue.2, pp.72-77, 2010.
DOI : 10.1016/j.cnd.2010.02.003

J. Walters, A. Tasleem, and O. Omer, A New Mechanism for Bile Acid Diarrhea: Defective Feedback Inhibition of Bile Acid Biosynthesis, Clinical Gastroenterology and Hepatology, vol.7, issue.11
DOI : 10.1016/j.cgh.2009.04.024

J. Rambaud, J. Buts, and G. Cortier, Flore microbienne intestinale : Physiologie et pathologie digestives, John Libbey EUROTEXT, 2004.

L. Hooper and J. Gordon, Commensal Host-Bacterial Relationships in the Gut, Science, vol.292, issue.5519, pp.1115-1118, 2001.
DOI : 10.1126/science.1058709

C. Landman and E. Quévrain, Le microbiote intestinal??: description, r??le et implication physiopathologique, La Revue de M??decine Interne, vol.37, issue.6, pp.418-423, 2016.
DOI : 10.1016/j.revmed.2015.12.012

R. Mackie, A. Sghir, and H. Gaskins, Developmental microbial ecology of the neonatal gastrointestinal tract, Am. J. Clin. Nutr, vol.69, pp.1035-1045, 1999.

M. Grönlund, O. Lehtonen, and E. Eerola, Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery

D. Goldmann, J. Leclair, and A. Macone, Bacterial colonization of neonates admitted to an intensive care environment, The Journal of Pediatrics, vol.93, issue.2, pp.288-293, 1978.
DOI : 10.1016/S0022-3476(78)80523-X

R. Bennet, M. Eriksson, and C. Nord, Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens, The Pediatric Infectious Disease Journal, vol.5, issue.5, pp.533-539, 1986.
DOI : 10.1097/00006454-198609000-00009

D. Filippo, C. Cavalieri, D. , D. Paola, and M. , Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa, Proc. Natl. Acad
DOI : 10.1023/A:1026096204727

T. Sakata, Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects of fermentable fibre, gut microbes and luminal trophic factors, British Journal of Nutrition, vol.64, issue.01, pp.95-103, 1987.
DOI : 10.1051/rnd:19810504

R. Hass, R. Busche, and L. Luciano, Lack of butyrate is associated with induction of Bax and subsequent apoptosis in the proximal colon of guinea pig, Gastroenterology, vol.112, issue.3, pp.875-881, 1997.
DOI : 10.1053/gast.1997.v112.pm9041249

M. Alam, T. Midtvedt, and A. Uribe, Differential Cell Kinetics in the Ileum and Colon of Germfree Rats, Scandinavian Journal of Gastroenterology, vol.202, issue.5, pp.445-451, 1994.
DOI : 10.1038/202884a0

C. Cherbuy, B. Darcy-vrillon, and M. Morel, Effect of germfree state on the capacities of isolated rat colonocytes to metabolize n-Butyrate, glucose, and glutamine, Gastroenterology, vol.109, issue.6, pp.1890-1899, 1995.
DOI : 10.1016/0016-5085(95)90756-4

F. Guarner and J. Malagelada, Gut flora in health and disease, The Lancet, vol.361, issue.9356, pp.512-519, 2003.
DOI : 10.1016/S0140-6736(03)12489-0

G. Gibson and M. Roberfroid, Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics, J. Nutr, vol.125, pp.1401-1412, 1995.

G. Gibson, H. Probert, and J. Loo, Dietary modulation of the human colonic microbiota: updating the concept of prebiotics, Nutrition Research Reviews, vol.129, issue.02, pp.259-275, 2004.
DOI : 10.1093/carcin/22.1.43

P. Ducrotté, Flore et syndrome de l???intestin irritable, Gastroent??rologie Clinique et Biologique, vol.34, issue.4, pp.56-60, 2010.
DOI : 10.1016/S0399-8320(10)70008-7

G. Barbara, V. Stanghellini, and G. Brandi, Interactions Between Commensal Bacteria and Gut Sensorimotor Function in Health and Disease, The American Journal of Gastroenterology, vol.10, issue.1, pp.2560-2568, 2005.
DOI : 10.1046/j.1365-2036.2000.00818.x

T. King, E. M. Hunter, and J. , Abnormal colonic fermentation in irritable bowel syndrome, The Lancet, vol.352, issue.9135, pp.1187-1189, 1998.
DOI : 10.1016/S0140-6736(98)02146-1

H. Lin, Small Intestinal Bacterial Overgrowth, JAMA, vol.292, issue.7, pp.852-858, 2004.
DOI : 10.1001/jama.292.7.852

M. Pimentel, E. Chow, and H. Lin, Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebocontrolled study, Am. J. Gastroenterol, vol.98, pp.412-419, 2003.

A. Balsari, A. Ceccarelli, and F. Dubini, The fecal microbial population in the irritable bowel syndrome, Microbiologica, vol.5, pp.185-194, 1982.

A. Kassinen, L. Krogius-kurikka, and H. Mäkivuokko, The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects, Gastroenterology, vol.133, issue.1, pp.24-33, 2007.
DOI : 10.1053/j.gastro.2007.04.005

E. Verdú, P. Bercik, and M. Verma-gandhu, Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice, Gut, vol.55, issue.2, pp.182-190, 2006.
DOI : 10.1136/gut.2005.066100

S. Collins, The Intestinal Microbiota in the Irritable Bowel Syndrome, Int. Rev. Neurobiol, vol.131, pp.247-261, 2016.
DOI : 10.1016/bs.irn.2016.08.003

M. Anitha, V. ?. Kumar, M. Sitaraman, and S. , Gut Microbial Products Regulate Murine Gastrointestinal Motility via Toll-Like Receptor 4 Signaling, Gastroenterology, vol.143, issue.4, pp.1006-1016, 2012.
DOI : 10.1053/j.gastro.2012.06.034

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458182

L. Crouzet, E. Gaultier, and C. Del-'homme, The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota, Neurogastroenterology & Motility, vol.58, issue.Suppl. 1, pp.272-282, 2013.
DOI : 10.1136/gut.2007.144543

G. Palma, M. Lynch, and J. Lu, Tu1797 The Adoptive Transfer of Anxiety and Gut Dysfunction From IBS Patients to Axenic Mice Through Microbiota Transplantation, Gastroenterology, vol.146, issue.5, p.845, 2014.
DOI : 10.1016/S0016-5085(14)63073-0

P. Zheng, B. Zeng, and C. Zhou, Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host???s metabolism, Molecular Psychiatry, vol.486, issue.6, pp.786-796, 2016.
DOI : 10.1016/j.arcmed.2012.07.006

J. Jailwala, T. Imperiale, and K. Kroenke, Pharmacologic Treatment of the Irritable Bowel Syndrome, Annals of Internal Medicine, vol.133, issue.2, pp.136-147, 2000.
DOI : 10.7326/0003-4819-133-2-200007180-00013

T. Poynard, C. Regimbeau, and Y. Benhamou, Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome, Alimentary Pharmacology and Therapeutics, vol.45, issue.3, pp.355-361, 2001.
DOI : 10.1016/0197-2456(86)90046-2

T. Poynard, S. Naveau, and B. Mory, Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome, Alimentary Pharmacology & Therapeutics, vol.33, issue.5, pp.499-510, 1994.
DOI : 10.1185/03007998009109464

D. Lesbros-pantoflickova, P. Michetti, and M. Fried, Meta-analysis: the treatment of irritable bowel syndrome, Alimentary Pharmacology and Therapeutics, vol.126, issue.4, pp.1253-1269, 2004.
DOI : 10.1056/NEJMoa011871

L. Bueno, Cibles th??rapeutiques, Gastroent??rologie Clinique et Biologique, vol.33, pp.59-67, 2009.
DOI : 10.1016/S0399-8320(09)71526-X

O. Chassany, B. Bonaz, D. Bruley, and S. Varannes, Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol - a randomized, double-blind, placebo-controlled study, Alimentary Pharmacology & Therapeutics, vol.15, issue.Suppl. 2, pp.1115-1123, 2007.
DOI : 10.7326/0003-4819-133-2-200007180-00013

URL : https://hal.archives-ouvertes.fr/inserm-00321611

L. Laure, Efficacité clinique des antispasmodiques musculotropes dans la douleur abdominale : revue systématique de la littérature et méta-analyse des essais cliniques randomisés contre placebo Available at: http://nuxeo.edel.univpoitiers .fr/nuxeo/site, pp.6293-6300, 2004.

P. T. and D. M. Bouteloup-c, Recommandations pour la pratique clinique dans la prise en charge et le traitement de la constipation chronique de l'adulte Available at, p.130126, 2008.

H. Mertz, Irritable bowel syndrome, N. Engl. J. Med, vol.349, pp.2136-2146, 2003.

R. Spiller, Q. Aziz, and F. Creed, Guidelines on the irritable bowel syndrome: mechanisms and practical management, Gut, vol.56, issue.12, pp.1770-1798, 2007.
DOI : 10.1136/gut.2007.119446

A. Quartero, V. Meineche-schmidt, and J. Muris, Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome, Cochrane Database Syst. Rev, p.3460, 2005.

A. Ford, P. Moayyedi, and B. Lacy, American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation, The American Journal of Gastroenterology, vol.10, issue.1, pp.2-26, 2014.
DOI : 10.1111/j.1524-4733.2007.00179.x

L. Brandt and W. Chey, An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome, The American Journal of Gastroenterology, vol.104, issue.1, pp.1-35, 2009.
DOI : 10.1038/ajg.2008.122

N. Hovdenak, Loperamide Treatment of the Irritable Bowel Syndrome, Scandinavian Journal of Gastroenterology, vol.22, issue.sup130, pp.81-84, 1987.
DOI : 10.1136/gut.22.8.658

B. Lavö, M. Stenstam, and A. Nielsen, Loperamide in treatment of irritable bowel syndrome-a double-blind placebo controlled study, Scand. J. Gastroenterol. Suppl, vol.130, pp.77-80, 1987.

P. Ducrotte, M. Dapoigny, and B. Bonaz, Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial, Alimentary Pharmacology and Therapeutics, vol.23, issue.4, pp.435-444, 2005.
DOI : 10.1046/j.1365-2036.1999.00678.x

URL : https://hal.archives-ouvertes.fr/inserm-00410559

F. Chang, C. Lu, and C. Chen, Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome, Journal of Gastroenterology and Hepatology, vol.5, issue.12, pp.2266-2272, 2007.
DOI : 10.1053/j.gastro.2005.11.058

. Anon, Compléments alimentaires et médicaments à base d'argile Available at: https://www.quechoisir.org/comparatif-complement-et-medicament-a-base-d-argile-n911, 2017.

F. Suarez, J. Furne, and J. Springfield, Failure of activated charcoal to reduce the release of gases produced by the colonic flora, The American Journal of Gastroenterology, vol.114, issue.1, pp.208-212, 1999.
DOI : 10.1056/NEJM199507063330101

M. Lecuyer, T. Cousin, and M. Monnot, Efficacy of an activated charcoal???simethicone combination in dyspeptic syndrome: Results of a placebo-controlled prospective study in general practice, Gastroent??rologie Clinique et Biologique, vol.33, issue.6-7, pp.478-484, 2009.
DOI : 10.1016/j.gcb.2008.09.021

P. Ducrotté, Syndrome de??l'intestin irritable: options th??rapeutiques actuelles, La Presse M??dicale, vol.36, issue.11, pp.1619-1626, 2007.
DOI : 10.1016/j.lpm.2007.03.008

J. Jackson, O. Malley, P. Tomkins, and G. , Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis11The opinions in this article represent those of the authors and are not to be construed, in any way, to represent those of the U.S. Army or the Department of Defense., The American Journal of Medicine, vol.108, issue.1, pp.65-72, 2000.
DOI : 10.1016/S0002-9343(99)00299-5

C. Xie, Y. Tang, and Y. Wang, Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis, PLOS ONE, vol.8, issue.2, p.127815, 2015.
DOI : 10.1371/journal.pone.0127815.s001

J. Tack, D. Broekaert, and B. Fischler, A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome, Gut, vol.55, issue.8, pp.1095-1103, 2006.
DOI : 10.1136/gut.2005.077503

S. Kuiken, G. Tytgat, and G. Boeckxstaens, The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study, Clin. Gastroenterol

G. Tabas, M. Beaves, and J. Wang, Paroxetine to Treat Irritable Bowel Syndrome Not Responding to High-Fiber Diet: A Double-Blind, Placebo-Controlled Trial, The American Journal of Gastroenterology, vol.36, issue.4, pp.914-920, 2004.
DOI : 10.1046/j.1365-2036.2001.01094.x

F. Creed, L. Fernandes, and E. Guthrie, The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome, Gastroenterology, vol.124, issue.2, pp.303-317, 2003.
DOI : 10.1053/gast.2003.50055

D. Ponti, F. Tonini, and M. , Irritable Bowel Syndrome, Drugs, vol.278, issue.3, pp.317-332, 2001.
DOI : 10.1111/j.1476-5381.1995.tb16340.x

L. Houghton, C. Fell, and P. Whorwell, Effect of a second-generation ??2?? ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome, Gut, vol.56, issue.9, pp.1218-1225, 2007.
DOI : 10.1136/gut.2006.110858

M. El-salhy and D. Gundersen, Diet in irritable bowel syndrome, Nutrition Journal, vol.62, issue.Suppl 2, p.36, 2015.
DOI : 10.1021/jf405138w

C. Melchior, M. Maccarone, and C. Lemaitre, Que reste-t-il en 2015??des r??gimes en h??patogastroent??rologie???, Nutrition Clinique et M??tabolisme, vol.29, issue.2, pp.101-108, 2015.
DOI : 10.1016/j.nupar.2015.03.002

J. Boclé, M. Champ, and J. Berta, Les fibres alimentaires : d??terminants physico-chimiques, d??finition, aspects analytiques et physiologiques, Cahiers de Nutrition et de Di??t??tique, vol.40, issue.1, pp.15-21, 2005.
DOI : 10.1016/S0007-9960(05)80462-6

L. Chevallier, 28 - Troubles fonctionnels intestinaux In: Nutrition : principes et conseils (3e édition) Available at: http://www.sciencedirect.com/science, pp.223-235, 2016.

C. Bijkerk, J. Muris, and J. Knottnerus, Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome, Alimentary Pharmacology and Therapeutics, vol.45, issue.3, pp.245-251, 2004.
DOI : 10.1136/gut.47.suppl_2.ii1

W. Heizer, S. Southern, and S. Mcgovern, The Role of Diet in Symptoms of Irritable Bowel Syndrome in Adults: A Narrative Review, Journal of the American Dietetic Association, vol.109, issue.7, pp.1204-1214, 2009.
DOI : 10.1016/j.jada.2009.04.012

P. Gibson and S. Shepherd, Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach, Journal of Gastroenterology and Hepatology, vol.85, issue.4, pp.252-258, 2010.
DOI : 10.1016/0016-5085(91)90112-X

. Ducrotté, Conseil de pratique : régime pauvre en sucres fermentiscibles, les " FODMAPs, 2016.

A. Marsh, E. Eslick, and G. Eslick, Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis, European Journal of Nutrition, vol.2, issue.1S, pp.897-906, 2016.
DOI : 10.1053/j.gastro.2006.07.015

E. Halmos, V. Power, and S. Shepherd, A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel??Syndrome, Gastroenterology, vol.146, issue.1, pp.67-75, 2014.
DOI : 10.1053/j.gastro.2013.09.046

L. Böhn, S. Störsrud, and T. Liljebo, Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial, Gastroenterology, vol.149, issue.6, pp.1399-1407, 2015.
DOI : 10.1053/j.gastro.2015.07.054

M. Coëffier, P. Déchelotte, and P. Ducrotté, Intestinal Permeability in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: Is There a Place for Glutamine Supplementation?, Gastroenterology, vol.148, issue.5, pp.1079-1080, 2015.
DOI : 10.1053/j.gastro.2015.02.057

Q. Zhou, W. Souba, and C. Croce, MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome, Gut, vol.59, issue.6, pp.775-784, 2010.
DOI : 10.1136/gut.2009.181834

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891786

Q. Zhou, S. Costinean, and C. Croce, MicroRNA 29 Targets Nuclear Factor-??B???Repressing Factor and Claudin 1 to Increase Intestinal Permeability, Gastroenterology, vol.148, issue.1, pp.158-169, 2015.
DOI : 10.1053/j.gastro.2014.09.037

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303568

J. Bertrand, I. Ghouzali, and C. Guérin, Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome, Journal of Parenteral and Enteral Nutrition, vol.123, issue.8, pp.1170-1176, 2016.
DOI : 10.1136/gut.2008.150425

C. Martínez, M. Vicario, and L. Ramos, The Jejunum of Diarrhea-Predominant Irritable Bowel Syndrome Shows Molecular Alterations in the Tight Junction Signaling Pathway That Are Associated With Mucosal Pathobiology and Clinical Manifestations, The American Journal of Gastroenterology, vol.176, issue.5, pp.736-746, 2012.
DOI : 10.1038/modpathol.3800704

J. Rapin and N. Wiernsperger, Possible links between intestinal permeablity and food processing: a potential therapeutic niche for glutamine, Clinics, vol.65, issue.6, pp.635-643, 2010.
DOI : 10.1590/S1807-59322010000600012

URL : http://doi.org/10.1590/s1807-59322010000600012

J. Spanier, C. Howden, and M. Jones, A Systematic Review of Alternative Therapies in the Irritable Bowel Syndrome, Archives of Internal Medicine, vol.163, issue.3, pp.265-274, 2003.
DOI : 10.1001/archinte.163.3.265

J. Lackner, C. Mesmer, and S. Morley, Psychological Treatments for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis., Journal of Consulting and Clinical Psychology, vol.72, issue.6, pp.1100-1113, 2004.
DOI : 10.1037/0022-006X.72.6.1100

W. Gonsalkorale, V. Miller, and A. Afzal, Long term benefits of hypnotherapy for irritable bowel syndrome, Gut, vol.52, issue.11, pp.1623-1629, 2003.
DOI : 10.1136/gut.52.11.1623

L. Roberts, S. Wilson, and S. Singh, Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial, Br. J. Gen. Pract. J. R. Coll. Gen. Pract, vol.56, pp.115-121, 2006.

H. Hagège, Les traitements alternatifs dans le syndrome de l???intestin irritable, Gastroent??rologie Clinique et Biologique, vol.33
DOI : 10.1016/S0399-8320(09)71528-3

D. Schumann, D. Anheyer, and R. Lauche, Effect of Yoga in the Therapy of Irritable Bowel Syndrome: A??Systematic Review, Clinical Gastroenterology and Hepatology, vol.14, issue.12, pp.1720-1731, 2016.
DOI : 10.1016/j.cgh.2016.04.026

A. Müller, H. Franke, and K. Resch, Effectiveness of Osteopathic Manipulative Therapy for Managing Symptoms of Irritable Bowel Syndrome: A Systematic Review, The Journal of the American Osteopathic Association, vol.114, issue.06, pp.470-479, 2014.
DOI : 10.7556/jaoa.2014.098

H. Amjad and H. Jafary, Foeniculum vulgare therapy in irritable bowel syndrome, The American Journal of Gastroenterology, vol.95, issue.9, p.2491, 2000.
DOI : 10.1111/j.1572-0241.2000.02633.x

J. Langhorst, R. Lauche, and A. Janzen, Sa1071 Efficacy of Caraway Oil Poultices in the Treatment of Irritable Bowel Syndrome -A Randomized Controlled Cross-Over Trial, Gastroenterology, vol.146, issue.5, p.192, 2014.
DOI : 10.1016/S0016-5085(14)60675-2

A. Fani, A. Malekirad, and A. Pooyandeh, Effect of Anisum on improvement of clinical symptoms of Irritable bowel syndrome, Toxicology Letters, vol.258, pp.131-132, 2016.
DOI : 10.1016/j.toxlet.2016.06.1519

G. Holtmann and N. Talley, Herbal Medicines for the Treatment of Functional and Inflammatory??Bowel Disorders, Clinical Gastroenterology and Hepatology, vol.13, issue.3, pp.422-432, 2015.
DOI : 10.1016/j.cgh.2014.03.014

R. Johri, Cuminum cyminum and Carum carvi: An update, Pharmacognosy Reviews, vol.5, issue.9, pp.63-72, 2011.
DOI : 10.4103/0973-7847.79101

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210012

A. Keshavarz, M. Minaiyan, and A. Ghannadi, Effects of Carum carvi L. (Caraway) extract and essential oil on TNBS-induced colitis in rats, Res. Pharm. Sci, vol.8, pp.1-8, 2013.

F. Nesslany, D. Parent-massin, and D. Marzin, Risk assessment of consumption of methylchavicol and tarragon: The genotoxic potential in vivo and in vitro, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol.696, issue.1
DOI : 10.1016/j.mrgentox.2009.11.003

A. Ford, N. Talley, and B. Spiegel, Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis, BMJ, vol.337, issue.nov13 2, p.2313, 2008.
DOI : 10.1136/bmj.a2313

A. Al-yasiry and B. Kiczorowska, Frankincense ??? therapeutic properties, Post??py Higieny i Medycyny Do??wiadczalnej, vol.70
DOI : 10.5604/17322693.1200553

R. Lauche, S. Kumar, and J. Hallmann, Efficacy and safety of Ayurvedic herbs in diarrhoea-predominant irritable bowel syndrome: A randomised controlled crossover trial, Complementary Therapies in Medicine, vol.26, pp.171-177, 2016.
DOI : 10.1016/j.ctim.2016.04.002

B. Brinkhaus, C. Hentschel, and G. Schindler, Is herbal medicine effective in irritable bowel syndrome? Results of a randomised, placebo-controlled, double-blind clinical trial, European Journal of Integrative Medicine, vol.1, p.26, 2008.
DOI : 10.1016/j.eujim.2008.08.134

P. Tailliez, Les lactobacilles : propri??t??s, habitats, r??le physiologique et int??r??t en sant?? humaine, Antibiotiques, vol.6, issue.1, pp.35-41, 2004.
DOI : 10.1016/S1294-5501(04)94231-8

F. Sébastien, P. Claire, and R. Johanna, Que savons-nous des probiotiques, Actual. Pharm, vol.2013, pp.18-21

F. Oms, Guidelines for the Evaluation of Probiotics in Food Available at, 2002.

S. Xiao, D. Zhang, and H. Lu, Multicenter, randomized, controlled trial of heat-killedLactobacillus acidophilus LB in patients with chronic diarrhea, Advances in Therapy, vol.24, issue.2S, pp.253-260, 2003.
DOI : 10.1093/clinids/8.5.771

A. Tarrerias, V. Costil, and F. Vicari, The Effect of Inactivated <i>Lactobacillus</i> LB Fermented Culture Medium on Symptom Severity: Observational Investigation in 297 Patients with Diarrhea-Predominant Irritable Bowel Syndrome, Digestive Diseases, vol.29, issue.6, pp.588-591, 2011.
DOI : 10.1159/000332987

O. Fao, Consultation mixte d'experts FAO/OMS sur l'évaluation des propriétés sanitaires et nutritionnelles des probiotiques dans les aliments, y compris le lait en poudre contenant des bactéries lactiques vivantes Available at, 2001.

P. Marteau and F. Shanahan, Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects, Best Practice & Research Clinical Gastroenterology, vol.17, issue.5, pp.725-740, 2003.
DOI : 10.1016/S1521-6918(03)00055-6

M. Martini, D. Smith, and D. Savaiano, Lactose digestion from flavored and frozen yogurts, ice milk, and ice cream by lactase-deficient persons. Am, J. Clin. Nutr, vol.46, pp.636-640, 1987.

. Syndifrais, Site internet Syndifrais : Syndicat National des Fabricants de Produits Laitiers Frais Available at: http://www.syndifrais.com, 2017.

S. Schneider and . Probiotiques, Available at: http://www.em-consulte.com/en, p.184303, 2008.

B. Flourié and N. S. , Propri??t??s fonctionnelles des probiotiques, Cahiers de Nutrition et de Di??t??tique, vol.42, pp.38-44, 2007.
DOI : 10.1016/S0007-9960(07)91320-6

P. Moayyedi, A. Ford, and N. Talley, The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review, Gut, vol.59, issue.3, pp.325-332, 2010.
DOI : 10.1136/gut.2008.167270

G. Aragon, D. Graham, and M. Borum, Probiotic Therapy for Irritable Bowel Syndrome, Gastroenterol. Hepatol, vol.6, pp.39-44, 2010.

A. Ford, E. Quigley, and B. Lacy, Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis, The American Journal of Gastroenterology, vol.16, issue.10, pp.1547-1561, 1562.
DOI : 10.1038/nm1521

J. Yoon, W. Sohn, and O. Lee, Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial, Journal of Gastroenterology and Hepatology, vol.35, issue.Suppl., pp.52-59, 2014.
DOI : 10.1016/S0168-1605(97)88066-X

A. Cayzeele-decherf, F. Pélerin, and S. Leuillet, CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis, World Journal of Gastroenterology, vol.23, issue.2, pp.336-344, 2017.
DOI : 10.3748/wjg.v23.i2.336

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5236513

N. Pedersen, N. Andersen, and Z. Végh, eHealth, Inflammatory Bowel Diseases, vol.20, issue.12, pp.16215-16226, 2014.
DOI : 10.1097/MIB.0000000000000199

R. Spiller, F. Pélerin, C. Decherf, and A. , Randomized double blind placebocontrolled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United Eur, Gastroenterol. J, vol.4, pp.353-362, 2016.

S. Drouault-holowacz, S. Bieuvelet, and A. Burckel, A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome, Gastroent??rologie Clinique et Biologique, vol.32, issue.2, pp.147-152, 2008.
DOI : 10.1016/j.gcb.2007.06.001

P. Ducrotté, P. Sawant, and V. Jayanthi, 299v (DSM 9843) improves symptoms of irritable bowel syndrome, World Journal of Gastroenterology, vol.18, issue.30, pp.4012-4018, 2012.
DOI : 10.3748/wjg.v18.i30.4012

O. Mahony, L. Mccarthy, J. Kelly, and P. , Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles, Gastroenterology, vol.128, pp.541-551, 2005.

A. Agrawal, L. Houghton, and J. Morris, DN-173???010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation, Alimentary Pharmacology & Therapeutics, vol.101, issue.Suppl. 1, pp.104-114, 2009.
DOI : 10.1016/0016-5085(87)90837-7

URL : https://hal.archives-ouvertes.fr/hal-00416261

P. Whorwell, L. Altringer, and J. Morel, Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome, The American Journal of Gastroenterology, vol.122, issue.7, pp.1581-1590, 2006.
DOI : 10.1016/j.jpeds.2005.05.015

S. Guglielmetti, D. Mora, and M. Gschwender, Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double-blind, placebo-controlled study, Alimentary Pharmacology & Therapeutics, vol.26, issue.Suppl 1, pp.1123-1132, 2011.
DOI : 10.1080/07315724.2007.10719648

URL : https://hal.archives-ouvertes.fr/hal-00625147

H. Kim, M. Camilleri, and S. Mckinzie, A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome, Alimentary Pharmacology and Therapeutics, vol.122, issue.2
DOI : 10.1046/j.1365-2036.2001.01094.x

M. Katan, Why the European Food Safety Authority was right to reject health claims for probiotics, Beneficial Microbes, vol.101, issue.2, pp.85-89, 2012.
DOI : 10.1016/S1081-1206(10)60219-0

M. Fumery, O. Corcos, and N. Kapel, Int??r??t et technique de la transplantation f??cale, Journal des Anti-infectieux, vol.15, issue.4
DOI : 10.1016/j.antinf.2013.10.002

F. Barbut, A. Collignon, and M. Butel, Le transfert de flore digestive??: une revue de la litt??rature, Annales Pharmaceutiques Fran??aises, vol.73, issue.1, pp.13-21, 2015.
DOI : 10.1016/j.pharma.2014.05.004

L. Peyrin-biroulet, M. Bigard, and . Gaz-digestifs, Gaz digestifs, EMC - H??pato-Gastroenterologie, vol.2, issue.4, pp.370-387, 2005.
DOI : 10.1016/j.emchg.2005.07.001